Linked Life Data

7973214

Source:http://linkedlifedata.com/resource/pubmed/id/7973214

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13-14
pubmed:dateCreated
1994-12-21
pubmed:abstractText
Three cancer trials groups have decided to combine data from their separate trials examining the role of chemotherapy with 5-FU and folinic acid in the adjuvant treatment of resected colorectal carcinoma. Decisions regarding the timing of the analyses of these data have had to consider the same issues that surround early termination of ongoing trials. This paper reviews this experience from the perspective of one of the groups. It emphasizes the significant impact on decision-making of international differences of opinion concerning treatment standards.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0277-6715
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1337-40
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
Timing the collaborative analysis of three trials comparing 5-FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) perspective.
pubmed:affiliation
National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston, Ontario.
pubmed:publicationType
Journal Article, Comparative Study